Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05910827
Title Study of an Anti-HER3 Antibody, HMBD-001, With Docetaxel +/- Cetuximab in Advanced Squamous Non-small Cell Lung Cancers
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Hummingbird Bioscience
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS

Facility Status City State Zip Country Details
GenesisCare North Shore RECRUITING Sydney New South Wales 2065 Australia Details
ICON Cancer Centre South Brisbane WITHDRAWN Brisbane Queensland 4101 Australia Details
Southern Oncology Clinical Research Unit RECRUITING Adelaide South Australia 5042 Australia Details
Peninsula & South Eastern Haematology and Oncology Group RECRUITING Frankston Victoria Australia Details
Cabrini Health WITHDRAWN Malvern Victoria 3144 Australia Details
Linear Clinical Research RECRUITING Perth Western Australia 6009 Australia Details
The Institute of Oncology, ARENSIA Exploratory Medicine Phase I Unit NOT_YET_RECRUITING Chisinau Moldova, Republic of Details
National Cancer Centre Singapore RECRUITING Singapore Singapore Details
Tan Tock Seng Hospital RECRUITING Singapore Singapore Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field